Researchers in England found that MRI-assessed tumor responses to neoadjuvant therapy can help in the planning of subsequent treatments.
The study found that 72 percent of good responders to chemotherapy or radiation were alive after five years, compared with 27 percent of poor responders.
Related Articles on Rectal Cancer:
Trans-Anal Minimally Invasive Surgery Introduced in California
Study: Just One Screening Reduces Colon Cancer Risk for Middle-Aged Patients
